In a recent Federal Register notice, the PTO announced a proposed rule requiring that any settlement agreement resolving a PTAB proceeding, even if such agreement occurs prior to a decision to institute an inter partes review...more
5/7/2024
/ Abbreviated New Drug Application (ANDA) ,
Biosimilars ,
Department of Justice (DOJ) ,
Drug Pricing ,
Executive Orders ,
Federal Register ,
Federal Trade Commission (FTC) ,
Inter Partes Review (IPR) Proceeding ,
Medicare Modernization Act ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry